查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1379125

2023-2028 年按產品、技術、測試類型和地區分類的新生兒篩檢市場報告

Newborn Screening Market Report by Product, Technology, Test Type, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年，全球新生兒篩檢市場規模達到9.56億美元。展望未來， IMARC Group預計到2028年市場規模將達到14.67億美元，2022-2028年複合年成長率（CAGR）為7.4%。人們對各種嚴重疾病的早期疾病檢測的認知不斷增強、政府的有利舉措以及醫療技術的創新以實現更準確的結果和疾病檢測的效率是推動市場的一些主要因素。

新生兒篩檢是一項重要的公共衛生方法，旨在確定嬰兒出生後不久的某些健康狀況。它是透過從嬰兒腳後跟抽取幾滴血來進行的。它甚至可以在症狀出現之前及早發現潛在的嚴重狀況。它有助於評估各種先天性疾病、代謝異常和遺傳疾病。除此之外，它還使醫療保健專業人員能夠透過預防或盡量減少這些情況的影響來及時採取干涉和治療措施。

目前，兒童對提高生活品質的需求不斷成長，支撐著市場的成長。除此之外，遺傳和代謝疾病的日益流行，以及全球出生率的上升，正在加強市場的成長。此外，對可改善結果並降低醫療成本的篩檢測試的需求不斷成長，正在對市場產生積極影響。除此之外，資料管理和分析工具的日益整合以提高新生兒篩檢的效率，為行業投資者提供了利潤豐厚的成長機會。此外，父母對整體健康和預防性醫療保健措施的日益關注正在推動市場的成長。與此一致，自動化和數位化在醫療保健領域的日益普及正在推動市場的成長。

新生兒篩檢市場趨勢/促進因素：

對早期疾病檢測的認知不斷提高

父母對早期疾病檢測的重要性的認知不斷提高，這有助於市場的成長。據此，早期疾病檢測有助於及時介入、改善治療結果並改善兒童的生活品質。它也有助於保障個人健康和福祉。除此之外，它還可以避免潛在的併發症，減輕醫療保健系統的負擔，並提高整體生活品質。此外，對提供早期疾病檢測的先進篩檢技術和醫療保健服務的需求不斷成長，也推動了市場的成長。

有利的政府舉措

各國管理機構正在鼓勵採用新生兒篩檢來預防和管理世界各地的健康狀況，這提供了積極的市場前景。此外，他們正在實施強制性新生兒篩檢計劃，這使得更多人口更容易獲得這些服務。他們也採取舉措，通常涵蓋一系列全面的疾病，並確保有效解決各種潛在的健康問題。此外，他們正在組織教育活動，向醫療保健提供者傳播知識，為人們提供指導。

因此，這些措施有助於提高大眾對全球早期發現疾病的好處的認知。

醫療科技創新

各個製造商正在迅速推進其醫療技術，以增強新生兒篩檢方法。此外，串聯質譜 (MS) 和脫氧核糖核酸 (DNA) 檢測等創新技術有助於提高疾病檢測的準確性和效率。這些技術能夠同時篩檢更廣泛的疾病，增強診斷能力，甚至可以及早辨識罕見疾病。除此之外，這些篩檢技術的出現鼓勵醫療保健提供者採用和提供這些服務。此外，科技的進步可以最大限度地減少侵入性、縮短恢復時間並提高患者的舒適度，同時提高醫療干預的速度。

新生兒篩檢產業細分：

IMARC Group提供了全球新生兒篩檢市場報告各細分市場主要趨勢的分析，以及 2023 年至 2028 年全球、區域和國家層面的預測。我們的報告根據產品、技術和測試類型對市場進行了分類。

按產品分類：

儀器

試劑

儀器代表最大的細分市場

該報告根據產品提供了詳細的市場細分和分析。這包括儀器和試劑。報告稱，儀器儀表佔最大部分。儀器為樣本採集、分析和結果解釋提供必要的工具，在篩選過程中發揮重要作用。這些設備包含多種技術，例如質譜系統、脫氧核糖核酸 (DNA) 分析儀和自動篩選平台。這些儀器旨在確保篩檢程序的準確性、效率和可重複性。它們使醫療保健專業人員能夠精確處理大量樣本，並促進各種疾病的早期檢測。此外，對可靠且方便用戶使用的儀器的需求不斷成長正在支持市場的成長。

按技術分類：

串聯質譜法

脈搏血氧儀

基於酵素的測定

DNA檢測

電泳

其他

串聯質譜佔據大部分市場佔有率

該報告基於該技術對市場進行了詳細的細分和分析。這包括串聯質譜法、脈搏血氧測定法、酵素測定法、DNA 測定法、電泳法等。根據該報告，串聯質譜法代表了最大的部分。串聯質譜是一種分析技術，用於新生兒篩檢，以識別一系列代謝紊亂。它涉及質譜分析的兩個階段，其中離子被破碎並分析以精確識別化合物。除此之外，它還提供了更高的準確性和速度，並且可以檢測罕見的疾病。與此一致的是，醫學領域的技術進步提高了串聯質譜的敏感度和特異性，從而改善了全世界嬰兒的健康結果。

按測試類型分類：

乾血斑測試

慢性心臟衰竭

聽力篩檢

乾血斑佔最大市場佔有率

該報告根據測試類型提供了詳細的市場細分和分析。這包括乾血斑測試、CCHD 和聽力篩檢。報告稱，乾血斑測試佔最大部分。乾血斑測試是一種非侵入性且廣泛使用的篩檢技術，涉及從新生兒腳跟收集少量血液到特殊的濾紙上。然後分析乾燥的血液樣本中是否存在與各種疾病相關的特定標記。除此之外，它還可以及早發現先天性甲狀腺功能低下症和鐮狀細胞疾病等疾病。此外，許多新生兒篩檢計畫越來越青睞乾血斑檢測，因為乾血斑檢測提供了樣本採集的便利性、運輸的便利性以及同時篩檢多種疾病的能力，這也促進了市場的成長。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美表現出明顯的主導地位，佔據最大的新生兒篩檢市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美佔據最大的市場佔有率。

由於先進的醫療基礎設施，北美佔據了最大的市場佔有率。此外，個人對新生兒篩檢的長期好處的認知不斷提高，正在加強該地區市場的成長。除此之外，有利的政府措施和法規也帶來了積極的市場前景。與此一致的是，對預防性醫療保健的日益關注正在支持北美地區市場的成長。

競爭格局：

各製造商正在投資研發 (R&D) 活動，以提供創新的篩選技術和方法。這包括改進串聯質譜等現有技術，並探索新方法來擴大檢測條件的範圍。此外，公司還透過在測試組中添加更多條件來提供更全面的篩選服務。除此之外，主要參與者正在專注於開發自動化系統，以簡化從樣本收集到結果解釋的篩選過程，以提高效率、減少人為錯誤並縮短週轉時間。此外，公司還專注於資料管理解決方案，以確保準確的記錄保存、輕鬆存取結果以及與電子健康記錄的資料整合。

該報告對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

安捷倫科技公司

寶貝公司

Bio-RAD 實驗室公司

Chromsystems 儀器與化學品有限公司

丹納赫公司

馬西莫公司

美敦力公司

內特斯醫療公司

珀金內爾默公司

RECIPE 化學品+儀器有限公司

賽默飛世爾科技公司

Trivitron 醫療保健

沃特世公司

最近的發展：

2022 年8 月，Trivitron Healthcare 在印度維沙卡帕特南AMTZ 園區開設了其卓越中心，擁有最先進的研發(R&D) 和製造設施，用於代謝組學、基因組學、新生兒篩檢和分子診斷。

2020 年 11 月，領先的醫療設備解決方案提供商 Natus Medical Inc. 收購了德國醫療設備公司 Babybe GmbH 及其專利的遠距母嬰通訊技術。 Babybe 技術已被添加到 Natus 市場領先的新生兒護理產品組合中。

2022 年11 月，PerkinElmer Inc. 宣布美國食品藥物管理局(FDA) 已授權銷售EONIS (TM) SCID-SMA 檢測試劑盒，供經過認證的實驗室用於體外診斷(IVD)，用於同時檢測脊椎新生兒肌肉萎縮症（SMA）和嚴重複合型免疫缺陷症（SCID）。

本報告回答的關鍵問題

  • 2022年全球新生兒篩檢市場規模有多大
  • 2023-2028年全球新生兒篩檢市場的預期成長率是多少
  • 推動全球新生兒篩檢市場的關鍵因素是什麼
  • COVID-19 對全球新生兒篩檢市場有何影響
  • 基於產品的全球新生兒篩檢市場區隔是怎樣的
  • 基於該技術的全球新生兒篩檢市場的細分如何
  • 根據測試類型，全球新生兒篩檢市場的細分如何
  • 全球新生兒篩檢市場的重點區域有哪些
  • 誰是全球新生兒篩檢市場的主要參與者/公司

本報告回答的關鍵問題

  • 2022年全球新生兒篩檢市場規模有多大？
  • 2023-2028年全球新生兒篩檢市場的預期成長率是多少？
  • 推動全球新生兒篩檢市場的關鍵因素是什麼？
  • COVID-19 對全球新生兒篩檢市場有何影響？
  • 基於產品的全球新生兒篩檢市場的細分如何？
  • 基於該技術的全球新生兒篩檢市場的詳細情形如何？
  • 根據測試類型，全球新生兒篩檢市場的細分如何？
  • 全球新生兒篩檢市場的重點區域有哪些？
  • 全球新生兒篩檢市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球新生兒篩檢市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：按產品分類的市場區隔

  • 儀器
    • 市場走向
    • 市場預測
  • 試劑
    • 市場走向
    • 市場預測

第 7 章：依科技分類的市場

  • 串聯質譜法
    • 市場走向
    • 市場預測
  • 脈搏血氧儀
    • 市場走向
    • 市場預測
  • 基於酵素的測定
    • 市場走向
    • 市場預測
  • DNA檢測
    • 市場走向
    • 市場預測
  • 電泳
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按測試類型分類的市場

  • 乾血斑測試
    • 市場走向
    • 市場預測
  • 慢性心臟衰竭
    • 市場走向
    • 市場預測
  • 聽力篩檢
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Baebies Inc.
    • Bio-RAD Laboratories Inc.
    • Chromsystems Instruments & Chemicals GmbH
    • Danaher Corporation
    • Masimo Corporation
    • Medtronic plc
    • Natus Medical Incorporated
    • Perkinelmer Inc.
    • RECIPE Chemicals + Instruments GmbH
    • Thermo Fisher Scientific Inc.
    • Trivitron Healthcare
    • Waters Corporation
Product Code: SR112023A4068

Abstract

The global newborn screening market size reached US$ 956 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,467 Million by 2028, exhibiting a growth rate (CAGR) of 7.4% during 2022-2028. The growing awareness about early disease detection of various severe diseases, favorable government initiatives, and innovations in medical technology for more accurate outcomes and efficiency of disease detection are some of the major factors propelling the market.

Newborn screening is a vital public health approach that is designed to identify certain health conditions in infants shortly after birth. It is performed through a few drops of blood taken from the heel of the baby. It allows for the early detection of potentially serious conditions, even before symptoms appear. It assists in assessing a wide range of congenital disorders, metabolic irregularities, and genetic diseases. Besides this, it enables healthcare professionals to initiate timely interventions and treatments by preventing or minimizing the impact of these conditions.

At present, the rising demand for enhanced quality of life among children is supporting the growth of the market. Besides this, the increasing prevalence of genetic and metabolic disorders, along with rising birth rates across the globe, is strengthening the growth of the market. Additionally, the growing demand for screening tests that offer improved outcomes and reduced healthcare costs is positively influencing the market. Apart from this, the increasing integration of data management and analysis tools to enhance the efficiency of newborn screening is offering lucrative growth opportunities to industry investors. Furthermore, the rising focus on holistic well-being and preventive healthcare measures among parents is bolstering the growth of the market. In line with this, the increasing popularity of automation and digitalization in the healthcare sector is propelling the growth of the market.

Newborn Screening Market Trends/Drivers:

Rising awareness about early disease detection

The rising awareness among parents about the critical importance of early disease detection is contributing to the growth of the market. In line with this, early disease detection assists in offering timely intervention, improved treatment outcomes, and enhanced quality of life for the child. It also aids in safeguarding individual health and well-being. Apart from this, it can avoid potential complications, reduce the burden on healthcare systems, and improve the overall quality of life. Furthermore, the increasing demand for advanced screening technologies and healthcare services that offer early disease detection is bolstering the growth of the market.

Favorable government initiatives

Governing agencies of various countries are encouraging the adoption of newborn screening to prevent and manage health conditions around the world, which is offering a positive market outlook. In addition, they are implementing mandatory newborn screening programs, which makes these services more accessible to a larger population. They are also taking initiatives that often cover a comprehensive panel of disorders and ensure that a wide range of potential health issues are addressed efficiently. Furthermore, they are organizing educational campaigns to spread knowledge among healthcare providers to provide guidance to people.

As a result, these initiatives benefit in generating awareness among the masses about the benefits of early detection of diseases across the globe.

Innovations in medical technology

Various manufacturers are rapidly advancing their medical technologies to enhance newborn screening methods. In addition, innovative techniques, such as tandem mass spectrometry (MS) and deoxyribonucleic acid (DNA)-based testing, assist in increasing the accuracy and efficiency of disease detection. These technologies enable the simultaneous screening of a broader range of disorders, enhance diagnostic capabilities, and allow for early identification of even rare conditions. Apart from this, the emergence of these screening technologies encourages healthcare providers to adopt and offer these services. Furthermore, advancements in technologies minimize invasiveness, reduce recovery times, and improve patient comfort while enhancing the speed of medical interventions.

Newborn Screening Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global newborn screening market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product, technology and test type.

Breakup by Product:

Instruments

Reagents

Instruments represents the largest market segment

The report has provided a detailed breakup and analysis of the market based on the product. This includes instruments and reagents. According to the report, instruments represented the largest segment. Instruments play an important role in the screening process by providing the necessary tools for sample collection, analysis, and result interpretation. These devices comprise a diverse range of technologies, such as mass spectrometry systems, deoxyribonucleic acid (DNA) analyzers, and automated screening platforms. These instruments are designed to ensure accuracy, efficiency, and reproducibility in the screening procedures. They enable healthcare professionals to process a high volume of samples with precision and facilitate the early detection of various disorders. Furthermore, the rising demand for reliable and user-friendly instruments is supporting the growth of the market.

Breakup by Technology:

Tandem Mass Spectrometry

Pulse Oximetry

Enzyme Based Assay

DNA Assay

Electrophoresis

Others

Tandem mass spectrometry accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the technology. This includes tandem mass spectrometry, pulse oximetry, enzyme based assay, DNA assay, electrophoresis, and others. According to the report, tandem mass spectrometry represented the largest segment. Tandem mass spectrometry is an analytical technique that is employed in newborn screening to identify a range of metabolic disorders. It involves two stages of mass spectrometry, where ions are fragmented and analyzed for precise identification of compounds. Apart from this, it offers enhanced accuracy and speed and can detect rare disorders. In line with this, technological advancements in the medical field enhance the sensitivity and specificity of tandem mass spectrometry that offers improved health outcomes for infants worldwide.

Breakup by Test Type:

Dry Blood Spot Test

CCHD

Hearing Screen

Dry blood spot holds the biggest market share

The report has provided a detailed breakup and analysis of the market based on the test type. This includes dry blood spot test, CCHD, and hearing screen. According to the report, dry blood spot test represented the largest segment. A dry blood spot test is a non-invasive and widely utilized screening technique that involves collecting a small amount of blood from the heel of a newborn onto a special filter paper. This dried blood sample is then analyzed for the presence of specific markers associated with various disorders. Apart from this, it enables early detection of conditions, such as congenital hypothyroidism and sickle cell disease. Moreover, the rising preference for dry blood spot tests in many newborn screening programs, as they offer the convenience of sample collection, ease of transportation, and the ability to simultaneously screen for multiple conditions, is bolstering the growth of the market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest newborn screening market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the presence of advanced healthcare infrastructure. In addition, the rising awareness about the long-term benefits of newborn screening among individuals is strengthening the growth of the market in the region. Apart from this, favorable government initiatives and regulations are offering a positive market outlook. In line with this, the increasing focus on preventive healthcare is supporting the growth of the market in the North America region.

Competitive Landscape:

Various manufacturers are investing in research and development (R&D) activities to provide innovative screening technologies and methods. This includes refining existing techniques like tandem mass spectrometry and exploring new approaches to broaden the scope of conditions detected. In addition, companies are providing a more comprehensive screening service by adding more conditions to their test panels. Apart from this, key players are focusing on developing automated systems that streamline the screening process, from sample collection to result interpretation, to enhance efficiency, reduce human error, and allow for faster turnaround times. Furthermore, companies are focusing on data management solutions to ensure accurate record-keeping, easy access to results, and data integration with electronic health records.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.

Baebies Inc.

Bio-RAD Laboratories Inc.

Chromsystems Instruments & Chemicals GmbH

Danaher Corporation

Masimo Corporation

Medtronic plc

Natus Medical Incorporated

Perkinelmer Inc.

RECIPE Chemicals + Instruments GmbH

Thermo Fisher Scientific Inc.

Trivitron Healthcare

Waters Corporation

Recent Developments:

In August 2022, Trivitron Healthcare inaugurated its centre-of-excellence with state-of-the-art research and development (R&D) and manufacturing facilities at AMTZ Campus, Vishakhapatnam, India for metabolomics, genomics, newborn screening, and molecular diagnostics.

In November 2020, Natus Medical Inc., a leading provider of medical device solutions, acquired German healthcare equipment company Babybe GmbH and its patented remote mother to baby communication technology. The Babybe technology has been added to Natus's market leading Newborn Care portfolio of products.

In November 2022, PerkinElmer Inc. announced that the U.S. Food and Drug Administration (FDA) has authorized the marketing of the EONIS™ SCID-SMA assay kit for in vitro diagnostic (IVD) use by certified laboratories for the simultaneous detection of spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns.

Key Questions Answered in This Report

  • 1. What was the size of the global newborn screening market in 2022?
  • 2. What is the expected growth rate of the global newborn screening market during 2023-2028?
  • 3. What are the key factors driving the global newborn screening market?
  • 4. What has been the impact of COVID-19 on the global newborn screening market?
  • 5. What is the breakup of the global newborn screening market based on the product?
  • 6. What is the breakup of the global newborn screening market based on the technology?
  • 7. What is the breakup of the global newborn screening market based on the test type?
  • 8. What are the key regions in the global newborn screening market?
  • 9. Who are the key players/companies in the global newborn screening market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Newborn Screening Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Tandem Mass Spectrometry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pulse Oximetry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Enzyme Based Assay
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 DNA Assay
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Electrophoresis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Test Type

  • 8.1 Dry Blood Spot Test
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 CCHD
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hearing Screen
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baebies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Chromsystems Instruments & Chemicals GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Danaher Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Masimo Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medtronic plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Natus Medical Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Perkinelmer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 RECIPE Chemicals + Instruments GmbH
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Trivitron Healthcare
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Waters Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Newborn Screening Market: Major Drivers and Challenges
  • Figure 2: Global: Newborn Screening Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Newborn Screening Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Newborn Screening Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Newborn Screening Market: Breakup by Test Type (in %), 2022
  • Figure 7: Global: Newborn Screening Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Newborn Screening (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Newborn Screening (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Newborn Screening (Reagents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Newborn Screening (Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Newborn Screening (Tandem Mass Spectrometry) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Newborn Screening (Tandem Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Newborn Screening (Pulse Oximetry) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Newborn Screening (Pulse Oximetry) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Newborn Screening (Enzyme Based Assay) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Newborn Screening (Enzyme Based Assay) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Newborn Screening (DNA Assay) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Newborn Screening (DNA Assay) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Newborn Screening (Electrophoresis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Newborn Screening (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Newborn Screening (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Newborn Screening (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Newborn Screening (Dry Blood Spot Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Newborn Screening (Dry Blood Spot Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Newborn Screening (CCHD) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Newborn Screening (CCHD) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Newborn Screening (Hearing Screen) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Newborn Screening (Hearing Screen) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Newborn Screening Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Newborn Screening Industry: SWOT Analysis
  • Figure 80: Global: Newborn Screening Industry: Value Chain Analysis
  • Figure 81: Global: Newborn Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Newborn Screening Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Newborn Screening Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Newborn Screening Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Newborn Screening Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 5: Global: Newborn Screening Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Newborn Screening Market: Competitive Structure
  • Table 7: Global: Newborn Screening Market: Key Players